1. Market Research
  2. > Pharmaceutical Market Trends
  3. > IMS Country Review 2016: Spain

IMS Country Review 2016: Spain

  • July 2016
  • -
  • IMS Health
  • -
  • 81 pages

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Table Of Contents

IMS Country Review 2016: Spain
Table of Contents
SECTION 1: SYNOPSIS OF THE HEALTHCARE MARKET 5
MARKET TRENDS 5
HEALTHCARE PROVISION 5
PRESCRIBING POLICY 6
PRICING SYSTEM 8
REGULATORY ENVIRONMENT 9
INDUSTRY ENVIRONMENT 10
CHANNELS OF DISTRIBUTION 11
SPAIN DATA COLLECTION 12
SECTION 2: COUNTRY SALES PERFORMANCE AND TRENDS 13
FIGURE 1: COUNTRY RANKING AMONGST 30 MARKETS WORLDWIDE 13
FIGURE 2: AUDITED MARKET TREND 14
FIGURE 3: LEADING 35 LOCAL COMPANIES 15
FIGURE 4: LEADING 35 CORPORATIONS 17
FIGURE 5: MARKET SHARE BY CORPORATE NATIONALITY 19
FIGURE 6: LEADING 15 THERAPEUTIC CLASSES (LEVEL 3) 2015 20
FIGURE 7: 15 FASTEST-GROWING THERAPEUTIC CLASSES (LEVEL 3) 2015 21
FIGURE 8-22: LEADING 15 THERAPEUTIC CLASS PROFILES 22
FIGURE 8: A10N DPP-IV INHIBITOR A-DIABS 22
FIGURE 9: A10P SGLT2 INHIBITOR A-DIABS 23
FIGURE 10: B1F DIRECT FACTOR XA INHIBS 24
FIGURE 11: C10A CHOLESTandTRIGLY.REGULATOR 25
FIGURE 12: J5B ANTIVIRALS EXCL ANTI-HIV 26
FIGURE 13: J5C HIV ANTIVIRALS 27
FIGURE 14: L1G MAB ANTINEOPLASTICS 28
FIGURE 15: L1H PROTEIN KINASE INH A-NEO 29
FIGURE 16: L4B ANTI-TNF PRODUCTS 30
FIGURE 17: L4X OTHER IMMUNOSUPPRESSANTS 31
FIGURE 18: N5A ANTIPSYCHOTICS 32
FIGURE 19: N7X ALL OTHER CNS DRUGS 33
FIGURE 20: R3F B2-STIMULANTS+CORTICOIDS 34
FIGURE 21: R7X ALL OTH RESP SYST PRODS 35
FIGURE 22: S1B CORTICOSTEROIDS-EYE 36
FIGURE 23: LEADING 40 PRODUCTS 37
FIGURE 24: LEADING 40 NEW PRODUCTS 39
FIGURE 25: LEADING 15 PRODUCT FORMS 42
FIGURE 26: FASTEST GROWING 40 PRODUCTS SALES TRENDS 43
SECTION 3: APPENDICES 45
APPENDIX 1: AUDITED UNIVERSE 45
APPENDIX 2: COUNTRY SPECIFIC ALERTS 46
APPENDIX 3: MEASURE INDEX 49
APPENDIX 4: SALES DATA MEASURES 51
APPENDIX 5: *LATEST FACTORS 53
APPENDIX 6: QUARTERLY US$ EXCHANGE RATES BY COUNTRY 57
APPENDIX 7: CORPORATIONS 59
APPENDIX 8: PRODUCT NAMES 60
APPENDIX 9: THERAPIES 62
APPENDIX 10: EPHMRA ANATOMICAL THERAPEUTIC CLASSIFICATION 63

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.